RE: Bi-Weekly Dosing study - progress?6 Mar 2024 15:02
Thorn,
I think we should all realise that PI's are not worth Jack to any company. We buy and sell as we see fit at any given time and it makes no diff the the actual company in question. They get none of the proceeds, so why should they care?
If we are all selling and it materially forces the SP down then thats because of bad/poor news. That would be down to the company not the PI's.
II's are taken more seriously because they hold much more stock and can influence director re-elections and ultimate recommendations to the private sector and such like, and of course are to be tapped up for future funding (if necessary).
I keep banging this drum but I think its important. PI's know jack about the company. They are not kept informed and only get updates after the event. "Research" is a pointless waste of time, other than in the broadest of terms.
This stock is in fact a great example. Look at the detailed posts on the science and dot joining both through the years of the LFT development and now the years of jus this early part of the trial.
Nothing has come to pass that these investors and detailed researchers here posted about. not one, single thing.
I have been more accurate in broad terms here only because I have used my experience in buying and selling to see the themes that seem to be universal in all listed companies being replicated here.
Common sense (which is another word for experience), is the best thing to develop to give you a fighting chance.